Genepharma now as Ascent Pharma

Genepharma will be called as Ascent Pharmaceuticals hereby...

"Two years ago when we launched our Australian generic portfolio into Asia, we created the Ascent brand. Today we are Singapore's biggest generic pharmaceutical company with fast growing businesses in Malaysia, Thailand, Hong Kong and Vietnam where Australian regulated generics are a premium product category," he said.

Source : http://www.pharmacynews.com.au/article/name-change-for-genepharm/514819.aspx

Patient Enrollment Complete In Tragara Pharmaceuticals' Phase2 Trial Of Capoxigem(R) In NSCLC

Tragara Pharmaceuticals, Inc. announced the completion of patient enrollment to its APRiCOT-L study, a phase II clinical trial of its oral, once-daily anti-cancer agent, Capoxigem® (apricoxib, TG01), in non-small cell lung cancer (NSCLC). The APRiCOT-L study is a randomized, double-blind, multi-center, placebo-controlled trial designed to evaluate Capoxigem in combination with erlotinib in second and third line NSCLC patients that have failed a platinum-containing regimen. 

Source : http://www.medicalnewstoday.com/articles/184621.php